TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›KVUE›Financials
Annual statements · SEC XBRL · FY2022 – FY2025

Kenvue Inc. (KVUE) financials

Income statement

Kenvue Inc. (KVUE) income statement, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Revenue$15.1B$15.4B$15.5B$15.1B
Revenue growth—2.6%0.1%-2.1%
Gross profit$8.42B$8.64B$8.96B$8.79B
Gross margin55.9%56.0%58.0%58.1%
Operating income$2.92B$2.51B$1.84B$2.41B
Operating margin19.4%16.3%11.9%16.0%
Net income$2.08B$1.66B$1.03B$1.47B
Net margin13.8%10.8%6.7%9.7%
EPS (diluted)$1.21$0.90$0.54$0.76

Cash flow

Kenvue Inc. (KVUE) cash flow, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Operating cash flow$334M$3.17B$1.77B$2.20B
Capital expenditures$295M$469M$434M$475M
Free cash flow$39.0M$2.70B$1.33B$1.72B
Share buybacks—$7.00M$235M$197M
Dividends paid$0.00$766M$1.55B$1.58B

Balance sheet

Kenvue Inc. (KVUE) balance sheet, annual, from SEC filings
Fiscal yearFY2022FY2023FY2024FY2025
Cash & equivalents$740M$1.17B$1.07B$1.06B
Total assets—$27.9B$25.6B$27.1B
Total liabilities—$16.6B$15.9B$16.3B
Long-term debt—$0.00——
Shareholders' equity$20.5B$20.0B$9.67B$10.8B
Retained earnings—$429M-$93.0M-$204M
Shares (wtd avg diluted)1.72B1.85B1.92B1.92B

Every figure is extracted from Kenvue Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is Kenvue Inc.'s annual revenue?
Kenvue Inc. (KVUE) reported $15.1B of revenue for fiscal year 2025 — down 2.1% from $15.5B in FY2024, per its annual report filed with the SEC.
Is Kenvue Inc. profitable?
Yes — KVUE earned $1.47B of net income in FY2025, a 9.7% net margin, per SEC filings.
What is Kenvue Inc.'s free cash flow?
$1.72B in FY2025 (operating cash flow $2.20B minus $475M of capital expenditures), from the SEC cash-flow statement.
Does KVUE pay a dividend?
Yes — Kenvue Inc. paid $1.58B in cash dividends during FY2025, per its SEC cash-flow statement.
Full KVUE analysis — verdict, score & filings →Is KVUE a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.